rs137868995

Variant summary

Our verdict is Likely pathogenic. The variant received 9 ACMG points: 11P and 2B. PM1PP2PP5_Very_StrongBP4BS2_Supporting

The NM_001080483.3(MYMK):​c.271C>A​(p.Pro91Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00192 in 1,613,944 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 2 hom. )

Consequence

MYMK
NM_001080483.3 missense

Scores

2
7
8

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:11U:1

Conservation

PhyloP100: 9.28

Publications

10 publications found
Variant links:
Genes affected
MYMK (HGNC:33778): (myomaker, myoblast fusion factor) Involved in myoblast fusion. Located in plasma membrane. Implicated in Carey-Fineman-Ziter syndrome. [provided by Alliance of Genome Resources, Apr 2022]
MYMK Gene-Disease associations (from GenCC):
  • Carey-Fineman-Ziter syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, ClinGen, Illumina
  • Carey-Fineman-Ziter syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PM1
In a chain Protein myomaker (size 220) in uniprot entity MYMK_HUMAN there are 5 pathogenic changes around while only 0 benign (100%) in NM_001080483.3
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 5 curated pathogenic missense variants (we use a threshold of 10). The gene has 0 curated benign missense variants. Gene score misZ: 0.76146 (below the threshold of 3.09). Trascript score misZ: 1.1389 (below the threshold of 3.09). GenCC associations: The gene is linked to Carey-Fineman-Ziter syndrome 1, Carey-Fineman-Ziter syndrome.
PP5
Variant 9-133519002-G-T is Pathogenic according to our data. Variant chr9-133519002-G-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 430839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.02295518). . Strength limited to SUPPORTING due to the PP5.
BS2
High Homozygotes in GnomAdExome4 at 2 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001080483.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYMK
NM_001080483.3
MANE Select
c.271C>Ap.Pro91Thr
missense
Exon 3 of 5NP_001073952.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYMK
ENST00000339996.4
TSL:2 MANE Select
c.271C>Ap.Pro91Thr
missense
Exon 3 of 5ENSP00000419712.2
MYMK
ENST00000413714.1
TSL:3
n.326C>A
non_coding_transcript_exon
Exon 3 of 4

Frequencies

GnomAD3 genomes
AF:
0.00124
AC:
189
AN:
152166
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000830
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00207
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00124
AC:
311
AN:
250752
AF XY:
0.00122
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000723
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000140
Gnomad NFE exome
AF:
0.00227
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00199
AC:
2905
AN:
1461660
Hom.:
2
Cov.:
31
AF XY:
0.00196
AC XY:
1425
AN XY:
727108
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33480
American (AMR)
AF:
0.000738
AC:
33
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000556
AC:
48
AN:
86256
European-Finnish (FIN)
AF:
0.000244
AC:
13
AN:
53212
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00243
AC:
2702
AN:
1111994
Other (OTH)
AF:
0.00159
AC:
96
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
180
360
540
720
900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00124
AC:
189
AN:
152284
Hom.:
0
Cov.:
32
AF XY:
0.00106
AC XY:
79
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41560
American (AMR)
AF:
0.00111
AC:
17
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4818
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00207
AC:
141
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00162
Hom.:
0
Bravo
AF:
0.00133
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00267
AC:
23
ExAC
AF:
0.00128
AC:
155
EpiCase
AF:
0.00218
EpiControl
AF:
0.00207

ClinVar

ClinVar submissions as Germline

Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
1
-
Congenital nonprogressive myopathy with Moebius and Robin sequences (5)
4
-
-
Carey-Fineman-Ziter syndrome 1 (4)
2
-
-
not provided (2)
1
-
-
MYMK-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.13
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.032
T
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.92
D
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.023
T
MetaSVM
Benign
-0.82
T
PhyloP100
9.3
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.1
N
REVEL
Uncertain
0.31
Sift
Benign
0.31
T
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.77
MVP
0.39
MPC
1.1
ClinPred
0.066
T
GERP RS
5.1
Varity_R
0.18
gMVP
0.72
Mutation Taster
=27/73
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137868995; hg19: chr9-136384124; API